Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

Abstract

The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa−/−) mice were generated by gene targeting and monitored for eight months. C1qa−/− mice had increased mortality and higher litres of autoantibodies, compared with strain-matched controls. Of the Clqa−/− mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Hans-Joachim Anders, Ramesh Saxena, … Chandra Mohan

References

  1. Walport, M.J. & Morgan, B.P. Complement deficiency and disease. Immunol. Today 12, 301–306 (1991).

    Article  Google Scholar 

  2. Lachmann, P.J. & Walport, M.J. Deficiency of the effector mechanisms of the immune response and autoimmunity. in Ciba Foundation Symposium: Autoimmunity and Autoimmune diseases (ed. Whelan, J.) 129, 149–171 (Wiley, Chichester, 1987).

    CAS  Google Scholar 

  3. McAdam, R.A., Goundis, D. & Reid, K.M.B. A homozygous point mutation results in a stop codon in the C1q B-chain of a Clq-deficient individual. Immunogenetics 27, 259–264 (1988).

    Article  CAS  Google Scholar 

  4. Bowness, P. et al. Hereditary C1q deficiency and systemic lupus erythematosus. Quart. J. Med. 87, 455–464 (1994).

    CAS  Google Scholar 

  5. Petry, F., Le, D.T., Kirschfink, M. & Loos, M. Nonsense and missense mutations in the structural genes of complement component C1q A and C chains are linked with two different types of complete selective C1q deficiencies. J. Immunol. 155, 4734–4738 (1995).

    CAS  PubMed  Google Scholar 

  6. Slingsby, J.H. et al. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum. 39, 663–670 (1996).

    Article  CAS  Google Scholar 

  7. Topaloglu, R. et al. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 50, 635–642 (1996).

    Article  CAS  Google Scholar 

  8. Petry, F., Izzet Berkel, A. & Loos, M. Multiple identification of a particular type of hereditary C1q deficiency in the Turkish population: review of the cases andadditional genetic and functional analysis. Human Genet. 100, 51–56 (1997).

    Article  CAS  Google Scholar 

  9. Petry, F. et al. The mouse C1q genes are clustered on chromosome 4 and show conservation of gene organisation. Immunogenetics 43, 370–376 (1996).

    CAS  PubMed  Google Scholar 

  10. Jevnikar, A.M., Slinger, G.G., Brennan, D.C., Xu, H.W. & Kelley, V.R. Dexamethasone prevents autoimmune nephritis and reduces renal expression of la but not costimulatory signals. Am. J. Pathol. 141, 743–751 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Baker, A.J. et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94, 2105–2116 (1994).

    Article  CAS  Google Scholar 

  12. Korb, L.C. & Ahearn, J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525–4528 (1997).

    CAS  PubMed  Google Scholar 

  13. LeFeber, W.P. et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J. Clin. Invest. 74, 1545–1551 (1984).

    Article  CAS  Google Scholar 

  14. Golan, T.D., Elkon, K.B., Gharavi, A.E. & Krueger, J.G. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J. Clin. Invest. 90, 1067–1076 (1992).

    Article  CAS  Google Scholar 

  15. Casciola-Rosen, L.A., Anhalt, G. & Rosen, A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317–1330 (1994)

    Article  CAS  Google Scholar 

  16. Rosen, A., Casciola-Rosen, L.A. & Ahearn, J. Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med. 181, 1557–1561 (1995).

    Article  CAS  Google Scholar 

  17. Casciola-Rosen, L.A., Rosen, A., Petri, M. & Schlissel, M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93, 1624–1629 (1996).

    Article  CAS  Google Scholar 

  18. Trinder, P., Faust, D., Petry, F. & Loos, M. Modulation of mRNA expression and secretion of C1q in mouse macrophages by anti-inflammatory drugs and cAMP: evidence for the partial involvement of a pathway that includes cyclooxygenase, protaglandin E2 and adenylate cyclase. Immunol. 84, 638–644 (1995).

    CAS  Google Scholar 

  19. Andrews, B.S. & Theofilopoulos, A.N. A microassay for the determination of hemolytic complement activity in mouse serum. J. Immunol. Methods 22, 273–281 (1978).

    Article  CAS  Google Scholar 

  20. Burlingame, R.W. & Rubin, R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods 134, 187–199 (1990).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark J. Walport.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Botto, M., Dell' Agnola, C., Bygrave, A. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19, 56–59 (1998). https://doi.org/10.1038/ng0598-56

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0598-56

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing